Sorafenib Tosylate N-Oxide
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

583840-03-3Sorafenib Tosylate N-Oxide

● In Stock

Catalogue No.:VL2020001
CAS No.:583840-03-3
Mol. Formula:C₂₁H₁₆ClF₃N₄O₄
Mol. Weight:480.82 g/mol

Additional information on CAS 583840-03-3

Parent drug

Sorafenib

IUPAC Name

4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide 1-Oxide

Synonyms

Sorafenib N-Oxide

Smiles

CNC(=O)C1=[N+](C=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)[O-]

Description

Sorafenib Tosylate N-Oxide (CAS No: 583840-03-3) Or 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide 1-Oxide, sorafenib N-oxide is involved in sorafenib metabolism pathway, Sorafenib is tyrosine kinase inhibitors, which is used in the treatment of various types of tumors and autoimmune diseases.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url